Inquiry
메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS

237개의 게시물이 있습니다.

NEWS 목록 : 번호, 제목, 첨부, 작성일, 조회로 구성
The 2nd edition​ of HIRONIC GLOBAL NEWSLETTER has been released!   Please send an email to "marketing2@hironic.com" if you have any questions. Thank you 
2023-03-30
HIRONIC participated in IMCAS 2023, which was held in Paris, France. We exhibited the advanced NEW DOUBLO, SILKRO, ULTRA VERA and PICOHIGH 300.Especially the advanced New Doublo was launched at this IMCAS 2023 for the first time, and there was a great deal of interests from dermatologists, distributors and relevant businessmen. More than 500 people visited our booth and we ran out of all product brochure we prepared.​ ​​   
2023-02-08
The 1st edition​ of HIRONIC GLOBAL NEWSLETTER has been released!    Please click the images below for detailed information.  Thank you and happy new year!   
2023-01-05
  If you are interested in ULTRA VERA's treatment effects on VL (Vaginal laxity) and VVA (Vulvovaginal atrophy),    Please click here to see full text!   https://www.mdpi.com/2077-0383/11/23/6980     
2022-12-16
  Hironic announced on the 18th that its main product, the MFU(Micro Focused Ultrasound) devices, have been selected as the world's top product.Organized by the Ministry of Trade, Industry and Energy, the world's top product selection system selects products and producers that meet certain requirements such as global market share and provides various direct and indirect support to promote trade of these products. This year, 66 products were selected.Hironic's high intensity focused ultrasound device was selected as the world's top product in 2016. It has been listed as a World-Class production company for six consecutive years, including HIFU.Products that correspond to the MFU are V-RO, NEW DOUBLO, ULTRAVERA, and DOUBLO GOLD etc.haezung2212@news1.kr 
2022-11-29
   HIRONIC announced on August 25th that it has obtained permission of changing to manufacture of medical devices in connection with the establishment of the second plant in Osong-eup, Cheongju. The permission of changing to manufacture of medical devices is an administrative measure of the Ministry of Food and Drug Safety, and medical devices can be manufactured according to the changes. The permission will allow HIRONIC to manufacture medical devices at its new Osong plant. HIRONIC is famous for developing HIFU technology second in the world and for the first time in Korea. It expects that the second plant and permits will dramatically improve the production capacity of medical devices such as V-RO and NEW DOUBLO and other consumables essential for beauty devices. According to HIRONIC, as the second plant is in full swing, it is considering continuous extension of production and additional production facilities at the plant site with changes in market conditions such as soaring demand for beauty medical services due to post-COVID 19 in the future.   Seokkwang Park, CEO of HIRONIC said that “HIRONIC’s manufacturing and quality management system has been officially recognized based on this new GMP certification. As a leader of quality management, we will follow quality management standards to provide new values and differentiated products to our customers.   https://www.etnews.com/20220825000255                                     
2022-09-27
   HIRONIC, a medical aesthetic company, announced on August 16th that it has selected Yuri Sung as the muse of its next generation flagship product “V-RO” Yuri Sung has returned to the main MC of KBS entertainment show "Can I Recall Separation?" for the first time in four years and has been steadily gaining popularity as a celebrity by continuing her activities in various fields. HIRONIC explained that Yuri Sung’s sophisticated and bright image and unique luxury were judged to be actress who could express the brand image that V-RO pursues. Meanwhile, “V-RO” is a skin beauty medical device that combines HIFU (High Intensity Focused Ultrasound) and RF (Radio Frequency) into one handpiece, and draws attention abroad under the name “NEW DOUBLO”   https://www.news1.kr/articles/4774330 
2022-09-27
      HIRONIC has unveiled a TV commercial with actress Yuri Sung about “V-RO” (NEW DOUBLO), a product that combines HIFU and RF. The advertisement video has been released on various channels such as tvN and YouTube since September 2. and the concept is that Yuri Sung draws a light stream that means energy in a space composed of V-RO (NEW DOUBLO) main color (blue), expressing the features of the equipment and premium images in a sophisticated way. The safety of V-RO (NEW DOUBLO), contact and movement detection sensors is luxuriously captured through "Safe" copy drawing. In addition, through "Synergy" copy drawing, the synergy effect of HIFU and RF is luxuriously showed.   Meanwhile, V-RO (NEW DOUBLO) is a product that combines two mechanisms of HIFU (High Intensity Focused Ultrasound) and RF (Radio Frequency) into one handpiece to create synergy effect. V-RO is exported under the model name “NEW DOUBLO”.   
2022-09-21
   Hironic, a company specializing in beauty medical devices, announced on 8th that its all-in-one radio frequency device  ‘Silkro (Korean model name ‘Gentlo’)’ has obtained U.S. Food and Drug Administration (FDA). After being certified with European CEMDD in July last year.​ "Silkro" is an all-in-one radio frequency solution that not only causes coagulation of cell tissue but also relieves pain by penetrating micro needles into the skin or transferring radio frequency energy into the skin through electrodes on the handpiece. The device has total of four handpieces: RM (RF Micro Needle), RN (RF Needle), RC (RF Circle), and RV (RF Venus).​  Among the four handpieces, the RM handpiece needles penetrates the skin and emits radio frequency energy into the skin. The needle tip comes in 25pin or 49pin needles which give users a choice to use in wide or smaller facial area.  The needle comes in two types: insulated, which energy is transferred only to the target point, and non-insulated, which energy is transferred from the entire needle, allowing the procedure to be designed according to the patient's concerns or skin characteristics.​  In addition, Silkro is equipped with Treatment Information System (TIS), which provides convenience with functions that manage the history of procedures such as the type of handpiece, energy value, and number of times used automatically when patient information is entered.​  An official from Hironic said, "Silkro is certified with CE MDD certification, and now has obtained U.S. FDA approval. This is a start for Hironic's radio frequency technology to expand in global market". He also added that with FDA approval, the company will target the North American market, which accounts for more than 40% of the global beauty and medical device market, as well as achieve high sales and long-term corporate growth."​​
2022-06-09
 Hironic (CEO Park Seok-kwang) won the grand prize in the beauty medical device category from the Money Today "2022 Consumer-selected Service Customer Satisfaction Awards" held at the Korea Press Center in Jung-gu, Seoul on the 21st. The "2022 Consumer-selected Customer Satisfaction Award" is an award that selects and awards companies by discovering next-generation promising service companies and companies that realize customer satisfaction in each field. Hironic is a company specializing in beauty medical devices that has succeeded in commercializing HIFU equipment in Korea. Following the launch of “DOUBLO”, a focused ultrasound lifting device using HIFU technology in 2011, “PICOHI”, which stably implements 300ps Pulse Duration, are leading the skin beauty medical device market. The new product "New Doublo" introduced by Hironic is a new concept of device that combines focused ultrasound (HIFU) and high frequency (RF) technology. By cross-irradiating the two technologies, New Doublo is attracting interest from many consumers by reducing treatment time and increasing treatment synergy. In addition, New Doublo and PICOHI, which are the main devices of Hironic, have equipment design and various functions considering user convenience. The RMS (Remote Management System) linked in the equipment allows the headquarters to check the condition of the equipment, allowing faster and more effective after services. "We are very grateful and committed to winning the award for five consecutive years, and we will continue to provide better services based on differentiated customer management," a Hironic official said. "Sales are increasing as the recently released New Doublo is receiving great attention and love, and we expect to have a fruitful 2022."​​​​​​
2022-04-28
 Hironic donates 10M Won to the Korean committee of UNICEF, supports business for Ukraine children. ​Hironic said on 15th that it has donated 10 million KRW to UNICEF's Korean Committee to help 7.5 million children who are threatened with their life and security by Ukraine's prolonged armed conflict. Hironic, which currently is thriving with HIFU-RF synergy: “New Doublo” and 300ps Pico laser: “PICOHI”, has been doing social contribution activity for ESG management. It has donated some of its profits since 2011, and recently, environmental pollution and climate change around the world have emerged as serious social problems, therefore has a history of singing contracts of selecting eco-friendly product companies as investment destinations to participate in carbon emission reduction and eco-friendly support activities.​The donation will be used for treatment, education, learning materials, and drinking water for Ukrainian children who are suffering from conflict. "Children are dream and hope for the future," a Hironic official said. "Many children who are threatened by Ukraine's armed conflict are asking for help, and I hope this donation will help them regain their daily lives as soon as possible to have a happy life."​​ 
2022-04-28
  HIRONIC has successfully participated in 'KIMES 2022 (the 37th International Medical & Hospital Equipment Show)' held at COEX in Samseong-dong, Seoul for 4 days from the 10th to the 13th March.   KIMES 2022 is a large international medical and hospital equipment exhibition held in Seoul, Korea. About 1,200 domestic and foreign companies participated and introduced various products such as advanced medical devices, hospital facilities, and medical information systems that reflect the rapidly changing medical environment.   HIRONIC has successfully launched ‘NEW DOUBLO’, the main equipment capable of performing focused ultrasound (HIFU) and high frequency (RF) treatments simutaneouly.   NEW DOUBLO is a device that shortens the treatment time and further increases the synergy effect of treatment by cross-irradiating the two technologies. In HIFU equipment, a contact sensor is applied in the cartridge, which prevents over-lapping treatment causing side effects. In addition, a pen-type handpiece allows easier to treatment in narrow and curved areas like the face. Moreover, NEW DOUBLO has 7 types of cartridges, so customized treatment for each skin layer is possible.   Other than the newly launched NEW DOUBLO, HIRONIC has displayed PICOHI (FDA and CE certified) and GENTLO (CE certified) – leading to another successful year with KIMES. 
2022-03-17
 HIRONIC announced that it has signed an investment contract with eco-friendly product company "Piece-on-Table" as a part of ESG (Environmental, Social and Governance) management. Hyronic plans to participate in the movement of carbon emission reduction and eco-friendly support activities and practice ESG management through this investment.  “Peace-on-Table” is a zero-waist certified company that wants to serve as a guide to zero-waist activities by using natural or recycled materials from the actual product manufacturing process to delivery under the slogan "The First Step for the Earth." HIRONIC is carrying out various social contribution activities for ESG management as well as investment in eco-friendly businesses. HIRONIC has provided scholarship every year for contributing to foster the social leaders since 2011 and its cumulative donation is 184 million won until this year. In addition, as environmental pollution and climate change have emerged as serious social problems around the world, HIRONIC’s executives and employees have also provided regular sponsorship to environmental organizations every month since July 2020. In order to preventing environmental pollution, its subsidiary company, ATTIBE, has changed the packaging materials into eco-friendly materials. An official from HIRONIC said, "HIRONIC has already recognized the seriousness of environmental pollution and regularly sponsored eco-friendly organizations and also it uses eco-friendly materials as packaging materials for subsidiaries' products." This investment is the result of the company's continued interest in environmental issues, and it will further establish itself as part of sustainable ESG management practices. 
2021-12-17
 Hironic Co. Ltd (6,700-0.45%) has been succeeded in obtaining permission to sell its new product "PicoHi" in the U.S. Hironic obtained PicoHi's pre-market license (510k) from the U.S. Food and Drug Administration (FDA) on the 19th. 510k can be received by proving its functional similarity with existing commercial devices. It can be sold in the U.S. after approval of 510k. PicoHi also received a European Medical Device Item Permit (CE-MDD) in June. Hironic CEO Park, Seok-kwang, who met at the Yong-In headquarters in Gyeonggi-do on the 25th, said, "We will participate in American and European conferences or exhibitions in next year when COVID-19 is alleviated." In addition to these countries, some are discussing distribution exclusive agreements. It is an area where local sales are possible with the permission of PicoHi such as Korea and Europe. PicoHi obtained a medical device manufacturing license from the Ministry of Food and Drug Safety(MFDS) in January year of 2021. PicoHi is an Nd;yag laser surgery device that removes pigmented particles such as freckles and tattoos with pico-second(PS) from the skin. Pico-second is "one trillionth of a second." This means that the laser irradiation interval is one trillionth of a second. This is 1,000 times shorter than nanoseconds (1 billionth of a billionth), which were mainly used in conventional laser devices. It is explained that the shorter the irradiation interval, the more powerful shock waves are generated, and the smaller the pigment particles can be split. If the particles become finer, it is easy to remove them. CEO Park compared, "If nanosecond makes rocks into gravel with blunt needles, pico-second splits gravel into sand with a thin needle." Hironic is not the first to develop and make a pico-second laser device. He emphasizes that the core of PicoHi is 300 Pico-second. The shorter the same pico-second, the smaller the particle. However, laser equipment must also evolve. CEO Park said, "The most ideal speed that can be implemented with equipment that is currently commercialized at home and abroad is 300 pico-seconds," adding, " PicoHi stably outputs 300 pico-seconds for a long time." It also plans to focus on selling another new focused ultrasound stimulation system device called "V-Ro," which was released in Korea in August. V-Ro is a device that cross-irradiates focused ultrasound (HIFU) and high frequency (RF) with one hand-piece. Focused ultrasound is a high heat generated when ultrasonic energy is collected in one place, helping to improve skin elasticity by contracting the fascia layer (SMAS) between fat and muscles in the skin. A representative product is Ulthera of German company Mertz. However, HIFU shocks the subcutaneous fat layer, accompanied by prickly pain. CEO Park said, " HIFU requires a break (tem) between investigations, and V-Ro relieves pain by shooting high frequencies that have a relaxation effect on skin muscles between focused ultrasound." Hironic has applied for sales permits in the U.S. and Europe under the product name "New Doublo." This year's sales are expected to exceed 20 billion Korean-Won based on consolidated financial statements. Last year, sales were 13 billion Korean-Won. Hironic posted sales of about 14.3 billion won by the third quarter of this year, including 6.4 billion Korean-Won in the third quarter. This is an increase of 55% compared to the same period last year-on-year. The cumulative operating profit in the third quarter increased by about 270% to 2.5 billion Korean-Won. It is explained that it recovered its growth from the aftermath of COVID-19 last year. CEO Park said, "As there are no special negative factors in the fourth quarter, we expect to achieve more than three quarters of results," adding, "We will be able to achieve higher targets next year than this year when the foundation for new products will be established." Plans for mid- to long-term growth are also underway. Hironic is building a second plant in Osong Biopolis District, Cheongju-si, Chungcheongbuk-do, with the aim of completing it early next year. It has a land area of 7,000㎡ and a total building area of 1,292㎡. The production capacity (KEPA) is expected to more than double. Plant 2 is scheduled to operate in earnest in the second half of next year. It is also seeking new businesses. CEO Park said, "We are looking for the company that will be a helper for new businesses other than medical devices."​ 
2021-12-17
 HIRONIC Co., Ltd., a Korean leading manufacturer of aesthetic-medical equipment, has announced "PICOHI gets the U.S. FDA approval in Oct, 2021". The PICOHI has been in the spotlight with its launch at the aesthetic-medical market. Now, its high quality standard has been proved by acquiring both CE MDD and U.S. FDA approval. With its market growth to Europe and Middle East offered by CE MDD early this year, this is a new cornerstone for developing its business chance in U.S. market which occupies more than 40% of the aesthetic-medical market demand.​ 
2021-10-21